Monday, August 31, 2026

GBP/EUR Bullish Momentum With A 1% Rise In The Last 21 Sessions

ViaNews Editorial Team

January 28, 2024

GBP/EUR Bullish Momentum With A 1% Rise In The Last 21 Sessions

(VIANEWS) - GBP/EUR (GBPEUR) has been up by 1.56% for the last 21 sessions. At 13:11 EST on Sunday, 28 January, GBP/EUR (GBPEUR) is $1.17.

GBP/EUR's yearly highs and lows, it's 5.056% up from its 52-week low and 0.612% down from its 52-week high.

Volatility

GBP/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.01%, a positive 0.07%, and a positive 0.18%, respectively.

GBP/EUR's highest amplitude of average volatility was 0.20% (last week), 0.16% (last month), and 0.18% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GBP/EUR's Forex is considered to be oversold (<=20).

News about

  • Eur/usd weekly forecast: incremental trend lower persists as traders fret - 28 January 2024. According to DailyForex on Sunday, 28 January, "The question for day traders is if the currency value of the EUR/USD has reached a durable support level and can be used to place wagers while looking for upside price action in the coming days?", "The currency pair may appear oversold, but the current price range of the EUR/USD may be seen as fair market equilibrium for the time being. "
  • Eur/usd edges up as US inflation print fuels fed rate cut speculation. According to FXStreet on Friday, 26 January, "Nevertheless, US Treasury bond yields reversed its course, climbing higher and putting a lid on the EUR/USD rise.", "Following the US data release, the EUR/USD advanced towards 1.0900 but failed to break yesterday's high, which could pave the way for a pullback to the 200-day moving average (DMA) at 1.0843. "
  • Eur/usd recovers near-term losses, but gains capped post-us PCE. According to FXStreet on Friday, 26 January, "Dollar bets continue to weigh on USD pairs, keeping EUR/USD leaning toward a near-term middle around 1.0850.", "Despite intraday tests into the low side, EUR/USD is set to continue languishing in an ongoing congestion pattern between the 50-day and 200-day SMAs at 11.0925 and 1.0850, respectively. "
  • Eur/usd seen at 1.0700/1.0500 on a 6/12m horizon – danske bank. According to FXStreet on Friday, 26 January, "While we recognise that our Fed (first cut in March) and ECB (first cut in June) forecasts, all else equal, are positive for EUR/USD in H1, we believe that the broader pricing in the G10 could be more decisive for the cross, as we perceive current market expectations for rate cuts to be excessive.", "We still maintain our bias towards selling EUR/USD on rallies in the near term, and we forecast EUR/USD at 1.0700/1.0500 on a 6/12M horizon."
  • Eur/usd: the downside looks open to the 1.0790/1.0800 area – ING. According to FXStreet on Friday, 26 January, "The downside for EUR/USD looks open to the 1.0790/1.0800 area now and 1.0875/1.0900 looks like stronger resistance. "

More news about GBP/EUR (GBPEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com